Skip to content

Role of Durwadi Ghrit in the treatment of Dushta Vrana or wound

To see the efficacy of Durwadi Ghrit in the management of Dushta Vrana (infected wound) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079480
Enrollment
60
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L02- Cutaneous abscess, furuncle and carbuncle Health Condition 2: L029- Cutaneous abscess, furuncle and carbuncle, unspecified

Interventions

None listed

Sponsors

Dr Kanak Lata Mishra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Post surgical wound infection 2. Traumatic infected wound 3. Diabetic wound 4. Infected wound

Exclusion criteria

Exclusion criteria: • Malignant ulcer • Tubercular ulcer • Syphilitic ulcer • Leprotic ulcer • Actinomyecetes • HIV (+) patient’s wound • HBsAg(+) patients wound

Design outcomes

Primary

MeasureTime frame
Finally the treatment will be assessed on assessment criteria of Dusta vrana Criteria for assessing clinical features ScorePainDischargeSlough tissue 0No painNodischarge/dry dressingNo slough tissue 1Localized feeling of pain during movement only but no feeling during restScanty occasional discharge & little wet dressingUp to 25% area covered with slough 2Localized feeling of pain even during rest but not disturbing the sleepOften discharge & with blood on dressing26 to 50% area covered with slough 3Localized continuous feeling of pain, radiating & not relieved by rest Profuse, continuous discharge which needs frequent dressingMore than 50% area covered with slough Timepoint: 1 month

Secondary

MeasureTime frame
This includes mainly size measurements, photography, and tracing. These are performed on weekly basis to estimate baseline wound status, recovery size measurements, validate overall treatment plan and to demonstrate short term response to treatment planTimepoint: 1 month

Countries

India

Contacts

Public Contactkanaklata misra

S. G. M. P. G. Ayurvedic college and hospital

indrajeetszmgzp@gmail.com9458514700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026